Pubblicazioni

Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: a case report

2017 - MEDICINE

Giannetta, Elisa; Isidori, Andrea M.; Durante, Cosimo; DI Gioia, Cira; Longo, Flavia; Tombolini, Vincenzo; Bulzonetti, Nadia; Graziadio, Chiara; Pofi, Riccardo; Gianfrilli, Daniele; Verrienti, Antonella; Carletti, Raffaella; Filetti, Sebastiano; Lenzi, Andrea; Baroli, Alberto

Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer

2017 - ANNALS OF ONCOLOGY

Ciuffreda, L; DEL CURATOLO, ANAIS; Falcone, I; Conciatori, F; Bazzichetto, C; Cognetti, F; Corbo, V; Scarpa, A; Milella, M

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (â¤16Â years) low grade gliomaÂ â A final report

2017 - EUROPEAN JOURNAL OF CANCER

Gnekow, A. K.; Walker, D. A.; Kandels, D.; Picton, S.; Perilongo, G.; Grill, J.; Stokland, T.; Sandstrom, P. E.; Warmuth-Metz, M.; Pietsch, T.; Giangaspero, F.; Schmidt, R.; Faldum, A.; Kilmartin, D.; De Paoli, A.; De Salvo, G. L.; Gnekow, A. K.; Slavc, I.; Perilongo, G.; Picton, S.; Walker, D.; Stokland, T.; Sandstrom, P. E.; Clausen, N.; Arola, M.; Jonsson, O. G.; Cruz, O.; Navajas, A.; Teijeiro, A.; Grill, J.; Kalifa, C.; Raquin, M. -A.; Verlooy, J.; Hans, V.; Pietsch, T.; Scheurlen, W.; Hainfellner, J.; Giangaspero, F.; Ironside, J.; Robson, K.; Skullerud, K.; Scheie, D.; Nn, ; Ruchoux, M. -M.; Jouvet, A.; Figarella-Branger, D.; Lellouch-Toubiana, A.; Warmuth-Metz, M.; Prayer, D.; Calderone, M.; Jaspan, T.; Bakke, S. J.; Vazquez, E.; Couanet, D.; Kortmann, R. D.; Diekmann, K.; Scarzello, G.; Taylor, R.; Lote, K.; Giralt, J.; Carrie, C.; Habrand, J. L.; Soerensen, N.; Czech, T.; Chumas, P.; Gustavson, B.; Zerah, M.; Wabbels, B.; Pinello, M. L.; Fielder, A.; Simmons, I.; Christoffersen, T.; Calaminus, G.; Brockmann, K.; Straeter, R.; Ebinger, F.; Hernaiz-Driever, P.; Lackner, H.; Kennedy, C.; Glaser, A.; Stromberg, B.; Indiano, J. M.; Rodary, C.; Bouffet, E.; Frappaz, D.; Faldum, A.; Emser, A.; De Salvo, G. L.; Stephens, S.; Machin, D.; Le Deley, M. -C.; Egeland, T.; Freemann, C.; Schrappe, M.; Sposto, R.

SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab

2017 - MEDICAL ONCOLOGY

Meattini, Icro; Curigliano, Giuseppe; Terziani, Francesca; Becherini, Carlotta; Airoldi, Mario; Allegrini, Giacomo; Amoroso, Domenico; Barni, Sandro; Bengala, Carmelo; Guarneri, Valentina; Marchetti, Paolo; Martella, Francesca; Piovano, Pierluigi; Vannini, Agnese; Desideri, Isacco; Tarquini, Roberto; Galanti, Giorgio; Barletta, Giuseppe; Livi, Lorenzo

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

2017 - THE LANCET ONCOLOGY

Gronchi, Alessandro; Ferrari, Stefano; Quagliuolo, Vittorio; Broto, Javier Martin; Pousa, Antonio Lopez; Grignani, Giovanni; Basso, Umberto; Blay, Jean-Yves; Tendero, Oscar; Beveridge, Robert Diaz; Ferraresi, Virginia; Lugowska, Iwona; Merlo, Domenico Franco; Fontana, Valeria; Marchesi, Emanuela; Donati, Davide Maria; Palassini, Elena; Palmerini, Emanuela; De Sanctis, Rita; Morosi, Carlo; Stacchiotti, Silvia; BaguÃ£Â©, Silvia; Coindre, Jean Michelle; Dei Tos, Angelo Paolo; Picci, Piero; Bruzzi, Paolo; Casali, Paolo Giovanni

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial

2017 - JOURNAL OF CLINICAL ONCOLOGY

Platzbecker, Uwe; Avvisati, Giuseppe; Cicconi, Laura; Thiede, Christian; Paoloni, Francesca; Vignetti, Marco; Ferrara, Felicetto; Divona, Mariadomenica; Albano, Francesco; Efficace, Fabio; Fazi, Paola; Sborgia, Marco; Di Bona, Eros; Breccia, Massimo; Borlenghi, Erika; Cairoli, Roberto; Rambaldi, Alessandro; Melillo, Lorella; La Nasa, Giorgio; Fiedler, Walter; Brossart, Peter; Hertenstein, Bernd; Salih, Helmut R.; Wattad, Mohammed; LÃ¼bbert, Michael; Brandts, Christian H.; HÃ¤nel, Mathias; RÃ¶llig, Christoph; Schmitz, Norbert; Link, Hartmut; Frairia, Chiara; Pogliani, Enrico Maria; Fozza, Claudio; D'Arco, Alfonso Maria; Di Renzo, Nicola; Cortelezzi, Agostino; Fabbiano, Francesco; DÃ¶hner, Konstanze; Ganser, Arnold; DÃ¶hner, Hartmut; Amadori, Sergio; Mandelli, Franco; Ehninger, Gerhard; Schlenk, Richard F.; Lo-Coco, Francesco

Radiologic Response Assessment in Pediatric Soft Tissue Sarcoma: Computed-Assisted Volume Evaluation

2017 - THE JOURNAL OF PEDIATRICS

Orsatti, G.; Beltrame, V.; Crimi, F.; Frigo, A. C.; Bisogno, G.; Stramare, R.

The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials

2017 - AMERICAN JOURNAL OF HEMATOLOGY

Molica, Matteo; Canichella, Martina; Alunni Fegatelli, Danilo; Colafigli, Gioia; Massaro, Fulvio; Latagliata, Roberto; FoÃ , Robin; Breccia, Massimo

Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150, decreases neuroblastoma tumorigenicity and increases chemosensitivity

2017 - CLINICAL CANCER RESEARCH

Odate, S.; Veschi, V.; Yan, S.; Lam, N.; Woessner, R.; Thiele, C. J.